NCT05676502View on ClinicalTrials.gov

Effects on Ventilation With NHF and Asymmetrical Nasal Cannulas

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

April 1, 2024

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

AIRVO 2

Patients with chronic obstructive pulmonary disease and chronic respiratory failure use Nasal High Flow therapy during daytime sessions of 1.5 h.

Trial Locations (1)

45136

RECRUITING

Georg N Nilius, Essen

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

Kliniken Essen-Mitte

OTHER